Back

An N-/L-type calcium channel blocker, cilnidipine, reduces electrical and structural atrial remodeling associated with atrial fibrillation in a chronic dog model

18 March 2019 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Moderated ePosters 9: new basic arrhythmia insight from around the world Arrhythmias EHRA Premium Access EHRA 2019

About the speaker

Photo
Doctor Jean-Baptiste Guichard

Hospital Clinic of Barcelona, Barcelona (Spain)

7 More presentations in this session

Presentation thumbnail
Pharmacological inhibition of NHE3 dependent intestinal sodium absorption reduced arrhythmogenic remodelling in rats
Doctor D. Linz (Maastricht, NL)
Abstract Slides
Presentation thumbnail
Antiarrhythmic action of melatonin is associated with its effects on ventricular spatiotemporal depolarization pattern
Doctor K. Sedova (Prague, CZ)
Abstract Slides
Presentation thumbnail
Gene expression changes in a novel mouse model of dyssynchrony and resynchronization in heart failure
Doctor M. Stahlberg (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Gap junction modulation is a major determinant of the mechanism and organisation of ventricular fibrillation and a potential therapeutic target
Doctor B. Handa (Nedlands, AU)
Abstract Slides
Presentation thumbnail
Independent sources of initial atrial activity as the cause of arrhythmia in a rat model of alcoholic cardiomyopathy
Doctor L. Kolik (Moscow, RU)
Abstract Slides

Access the full session

Session thumbnail
Moderated ePosters 9: new basic arrhythmia insight from around the world

The Event

Event poster

EHRA 2019

18 March 2019 10:05 CET
You may be interested in
thumbnail
Congress Session
Risk stratification
thumbnail
Congress Session
Malignant arrhythmias
thumbnail
Congress Session
Novel arrhythmia treatments

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources